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21 Abstract 
22 Learning and memory abilities are altered in disorders of the serotonergic system, in disorders such as 
23 such as depression , phobias, and post-traumatic stress disorder (PTSD). Among the processes impaired 
24 by emotional distracters , and whose dysregulation is documented in affective disorders, is the ability to 
25 time in the seconds-to-minutes range, i.e ., interval timing. Presentation of distracters during timing 
26 tasks result in delays in responding suggesting a failure to maintain subjective time in working memory, 
27 as proposed by the Relative Time-Sharing (RTS) model. We investigated the role of the prelimbic cortex 
28 in the detrimental effect of anxiety-inducing distracters on the cognitive ability to interval time, using 
29 local infusions of selective serotonin reuptake inhibitor (SSRI) fluoxetine in a modified peak -interval 
30 procedure with neutral and anxiety-inducing distracters. Given that fluoxetine has beneficial effects on 
31 decreasing emotional responses to negative events, we hypothesized that fluoxetine would improve 
32 working memory in trials with distracters. Our results revealed a dissociation of the effects of fluoxetine 
33 infusion in the pre limbic cortex on interval timing and resource allocation (working memory for time), 
34 when neutral and anxiety-inducing distractions occurred. Fluoxetine was effective only during trials with 
35 distracters, but not during trials without distracters. Moreover, fluoxetine reduced the harmful effect of 
36 the distracters not only when the distracters were anxiety-inducing, but in fact exacerbated their 
37 detrimental effects on working memory when they were neutral. Results are discussed in relation to the 
38 brain circuits involved in RTS of resources, and the pharmacological management of affective disorders . 
39 
40 Keywords: Interval timing, serotonin, SSRI, fluoxetine, mPFC 
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42 Intr oductio n 
43 Learning, memory and emotional processing are dysregulated in affective disorders such as depression, 
44 phobias, and post-traumatic stress disorder {PTSD) resulting in anxiety and altered perception of events 
45 e.g. (Etkin et al, 2011; Gil and Droit-Volet, 2009; Hermann et al, 2009; Lui et al, 2011; Ritchey et al, 
46 20llj. For example, perception is hindered in individuals with PTSD (Terr, 1983), due to an attentional 
47 bias towards novel or emotionally charged stimuli (Kimble et al, 2000) . Effective therapies for these 
48 disorders include traditional psychotherapy (Bleiberg and Markowitz, 2005), putative cognitive 
49 enhancers; (Steckler and Risbrough , 2012), and pharmacotherapy {Fletcher et al, 2010), prominently 
50 targeting serotonin. Indeed , among the most commonly prescribed antidepressants , 10 out of the top 
51 12 target serotonin (Cipriani et al, 2009). In particular, selective serotonin reuptake inhibitors (SSRI) and 
52 putative cognitive enhancers {Floresca and Jentsch, 2011), such as fluoxetine (Prozac©), have beneficial 
53 reductive effects on affective disorder symptoms (Koen and Stein , 2011). 
54 One locus of putative serotonergic action is the frontal cortex, responsible for higher-order executive 
55 tasks and functions (Robbins and Arnsten, 2009). Frontal cortex is strongly innervated by serotonin 
56 neurons {Lambe et al, 2011) and its damage has severe effects on personality and decision making {Van 
57 Horn et al, 2012). Given the prominent expression of serotonergic receptors in the prefrontal cortex 
58 {PFC), a strong modulatory effect by serotonin was ascribed to this region {Puig and Gulledge, 2011). 
59 Therefore, we sought to assess the effects of PFC fluoxetine infusion on cognitive function in the 
60 presence of neutral of negative emotional distracters. 
61 Among the processes im paired by emot ional distracters, and whose dysregulation is documented in 
62 affective disorders, is the ability to time in the seconds-to-minutes range, i.e., interval timing . 
63 Timekeeping is indeed affected in depression {Droit-Volet, 2013), phobias (Hermann et al, 2009), 
64 schizoaffective disorders (Lee et al, 2009) and PTSD {Terr, 1983). Presentation of task-irrelevant 
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65 distracters during a timing task results in a considerable delay in responding {Buhusi, 2012; Buhusi and 
66 Meck, 2009; Matthews et al, 2012), suggesting a failure to maintain subjective time in working memory, 
67 possibly due to attentional and working memory resources being diverted away from timing {Buhusi et 
68 al, 2009). Resource re-allocation is exacerbated by anxiety-inducing task-irrelevant distracters, resulting 
69 in impairing effects. Most interestingly for the purposes of this paper, antidepressant medication 
70 reduces the effect of emotional distracters on interval timing (Matthews et al, 2012). 
71 Previous interval timing tasks have shown that the mPFC of is implicated in the ability of distracters to 
72 modulate behaviors, and for pharmaceutical manipulations to mediate the negative aspects of the 
73 distracter. Matthews et al (2012) showed that anxiety-inducing distracters distractibility can be 
74 modulated by antidepressant effects focusing on the blockage of dopamine and norepinephrine 
75 reuptake within the mPFC of rats. However , serotonin reuptake has also been implicated in anxiety, and 
76 is one of the most common forms of pharmaceutical management of anxiety (Cipriani et al, 2009). The 
77 serotonin transporter (SERT) has been detected in high density within the cortex of rats (Sur et al, 1996), 
78 and serotonin's post synaptic terminals are also found in great abundance within the mPFC (Puig et al, 
79 2011). Unfortunately, the influence of serotonin upon timing with emotional distracters has not been 
80 fully e lucidated. 
81 We investigated the role of the prelimbic cortex in the detrimental effect of anxiety-inducing task-
82 irrelevant distracters on the cognitive ability to keep track of time, using local infusions of selective 
83 serotonin reuptake inhibitor (SSRI) fluoxetine in a modified peak -interval procedure with neutral and 
84 anxiety-inducing distracters. Given that fluoxetine has benef icial effects on attention and working 
85 memory, e.g., decreasing emotional response to negative events, we hypothesized that fluoxetine 
86 would! improve maintenance of information in working memory in trials with distracters, resulting in a 
87 decrease of the disruptive effect of emotional events on the timekeeping abilities. 
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88 Methods 
89 Subjects. Thirty -thr ee naive 3-4 months old male Sprague-Dawley rats were used . Experimental 
90 procedures were co nducted in accordance with the National Institute of Health's Guide for the Care and 
91 Use of Laboratory Animals {2011). 
92 Apparatus. We used 12 standard rat operant chambers (MED Associates, St. Albans, VT) housed in 
93 sound attenuating cubicles, of which 4 were used for fear conditioning and the other 8 for interval 
94 timing. An 85 -dB white noise produced by a white-noise generator was first used during fear 
95 conditioning, and then later used as an anxiety-inducing distracter during the timing task . The 
96 conditioning chambers and the int erval timing chambers were made distinctive by uin g different box 
97 configurat ions , and different visual, auditory, and odor cues Matthews et al. The fear conditioning 
98 chambers contained a dipper entry space for a liquid dipper (no t used). Additionally, no levers were 
99 inserted in th e boxes at any tim e, and no food was ever given. Pine pellets were placed in the waste pan. 
100 In these boxes the grid floor was connected to shockers and scramblers genera ting a 1-s 0.85-mA foot 
101 shock. In contrast, the interval timing chambers contained two levers situated on the front wall of the 
102 cham ber, of which, only the left lever was used . Forty-five mg precision food pellets were delivered as a 
103 reinforcer. The to-be-timed visual stimulus was a 28-V 100-mA house light. A 66-dB background sound 
104 produced by a ven tilation fan was present throughout the timing session . 
105 Interval timing. After autosh aping, rats received fixed Interval (Fl) training sessions, during which the 
106 first lever press after 40s was reinforced by food delivery. Afterwards, rats received Fl trials randomly 
107 interm ixed with non-reinforced peak interval (Pl) probe trials . Matthews et al 
108 Fear conditioning. Rats were randomly assigned into two groups . FEAR rats received 6 pairings of noise 
109 followed by foot shock . NEUTRAL rats were treated identically , but no shock was presented. Rats 
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110 received two 30min fear conditioning sessions, one before and one after recovery from surgery, and one 
111 fear cond itionin g session between each testing session. 
112 Surgery. Twenty-six-gauge bilateral cannula guides were implanted in aseptic surgery under isoflurane 
113 anesthes ia into the prelimbic cortex {AP 2.5mm , ML ±0.6mm, DV -3.Smm). Rats were given at least 6 
114 recovery days before resuming timing and conditioning procedures. Rats received 6 Pl re-training 
115 sessions before Pl+N testing. 
116 Fear test session . After surgery recovery, FEAR rats received 2 presentations of the noise in extinction 
117 followed by 2 noise-shock pairings, at 4min intervals. NEUTRAL rats received no shocks during the fear 
118 test. Session lasted 20 minutes. 
119 Local infusions. Cannulae injectors aiming at mPFC were lowered into the cannula guides, extending 
120 1mm below the guides. Rats received 0.SµL infus ions of either vehicle (n 5% DMSO in saline) or 6µg/side 
121 or 0.6µg/side selective serotonin reuptake inhibitor (SSRI} fluo xetine (fluoxetine hydrochloride, Sigma 
122 Aldrich, St. Louis, MO}, dissolv ed in vehicle . Infusion order was counterbalanced. See below. 
123 Timing test sessions with noise and drug infusion. Rats received local drug infu sion s followed by a 3hr 
124 session of interval timing testing, during which rats received Fl and Pl trials randomly intermixed with Pl 
125 trials with noise {Pl+N) . Pl+N trials were similar to Pl trials, except that the 5-s white noise was 
126 presented {during to-be-timed stimulus}, Ss from the onset of the trial. Infusion sessions were separated 
127 by 3 retraining sessions. 
128 His tology . Rats were anesthetized with isoflurane overdose and transcardially perfused with formalin . 
129 Brain sections placed on slides, and stained with crystal vio let for histological verification {Figurel}. 
130 Seven rats were e limina ted due to incorrect cannula placement, lost cannulae , failure to acquire the 
131 timing task. {NEUTRAL n=l4, FEAR n=l3) 
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132 === Figure 1 about here=== 
133 
134 Doto Collection and Analysis. Lever presses during Pl and Pl+N trials were recorded through a MED 
135 Associates interface. Analyses were conducted on a 100s interval-of-interest starting at the onset of the 
136 to-be-timed signal for all Pl trials, and a 20-120s window for Pl+N trials. The average response rate was 
137 analyzed as to eva luate : th e accuracy of timing (peak time), precision of timing (width of response 
138 function), and peak rate of response. A delay in peak timing in Pl+N trials relative to Pl trials was 
139 computed and analyzed statistically {Buhusi and Meck, 2000). 
140 We further investigated the effect of the presentation of the noise and the effect of the drug on the 
141 dynamics of timing behavior during individual trials. Briefly, during individual trials, the distribution of 
142 lever presses can be approximated by a low-high-low function. Analysis algorithms described in 
143 {Swearingen and Buhusi, 2010) were used to extract the start and stop times. The start time is the time 
144 at which there is a significant increase in response rate during the trial (from the low-to-high states). The 
145 stop time is the point during the trial at which there is a signi ficant decrease in response rate (from the 
146 high -to - low states). Pl Trials without temporal control {abo ut 17% [ARMl)of total trials) were e liminated 
147 from individual -trial analyses and there were no exclusion criteria for Pl+N trials. 
148 Freezing behavior was recorded and scored (in 2.5 s bins) by two independ ent observers {93.24 ± 1.24% 
149 agreement) . The percent freezing behavior after the presentation of the noise in extinction was 
150 analyzed to evaluate the fear expression ind exe d by the rate of decay of freezing behavior after the 
151 presentation of the noise in extinction. Less fear expression was indexed by more negative decay rates 
152 while more fear expression was indexed by more positive decay rates. 
153 Timing accuracy (peak time), timing delay after noise , timing precision (width of function), and the start , 
154 stop, and median times were submitted to mixed ANOVAs of peak time, with between -subject variable 
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155 group {FEAR, NEUTRAL) and within-subject variables triai type {Pl, Pl+N) and drug {VEH, FLX 0.6ug, FLX 
156 6ug) were followed by Fisher LSD post-hoc comparisons. To further evaluate the relationship between 
157 timing delay and fear expression, the slope of regression lines were calculated using t -tests. Analyses 
158 were conducted in SPSS v21 {IBM Corp, Armonk, NY) and Statistica v8 {StatSoft, Tulsa, OK). Statistical 
159 tests were evaluated at a significance level of 0.05. 
160 Results 
161 No effect of fluoxetine on timing in the absence of distracters. Rats in both groups' timing peaked 
162 about the 40s criterion in Pl trials, suggesting that fluoxetine has no effect on interval timing in the 
163 absence of distracters {Figure 2). These results were supported by a repeated measures mixed ANOVA 
164 on Pl times with between-subjects variable {NEUTRAL, FEAR) and within-subject variable drug condition 
165 {VEH, FLX 0.6ug, FLX 6ug), which failed to indicate a reliable effect of the drug condition on the average 
166 peak time, F{2,50) = 2.29. These results suggested that fluoxetine has no effect on working memory for 
167 time without distraction. 
168 === Figure 2 about here=== 
169 Fluoxetine decreases distractibility of negative emotional events, but increases distractibility by 
170 neutral events. In Pl+N trials, fluoxetine infusion decreased the delay relative to Pl trials by negative 
171 emotional events in FEAR rats, but increased distractibility {large delays) by neutral events in NEUTRAL 
172 rats. To evaluate these results we computed a delay in peak time in Pl+N trials (with noise) relative to Pl 
173 trials (without noise), by subtracting the estimated peak time in Pl trials from the estimated peak time in 
174 Pl+N trials {Figure 3). A mixed ANOVA of the time delay with between-subjects variable {NEUTRAL, FEAR) 
175 and within-subject variable drug condition (VEH, FLX 0.6ug, FLX 6ug) indicated a main effect of group, 
176 F{l,25)=4 66, as well as a group x condition interaction , F{2,50)=9 .69, however failed to find a reliable 
177 main effect of drug condition, F{2,50)=0.72. These results suggested that fluoxetine appeared to have a 
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178 differential effect upon the distractibility of the groups during the working memory for· time task when 
179 emotiona l distractions were given. 
180 === Figure 3 about here=== 
181 No effect of fluoxetine on timing precision or response rate. Mixed ANOVAs of timing precision (width 
182 of response function) with between-subjects variable (NEUTRAL, FEAR) and within-subject variabie drug 
i83 condition (VEH, FLX 0.6ug, FLX 6ug) failed to indicate significant effects of group, drug, or interactions, 
184 all Fs < 3.09. These results suggested that the response curves in Pl+N sessions were simply delayed 
185 from Pl sessions, indicative of a delay in responding and not an difference in responding placement. 
186 Individual-trial analyses support fluoxetine effects. Mixed ANOVAs of the start, stop , and median times 
187 in Pl trials with between -subjects variable (NEUTRAL, FEAR) and within -subject variable drug condition 
188 (VEH, FLX 0 .6ug, FLX 6ug) failed to indicated any differences during Pl trials , all Fs < 4.0. These results 
189 supported the finding that fluoxetine had no effect in Pl trials . 
190 === Figure 4 about here=== 
191 However, significant differences in the start, median, and stop times in the Pl+N trials existed supporting 
192 the previous results that suggested that the effect of fluoxetine was only seen during distracted trials. 
193 Mixed ANOVAs of the start, stop, and median times indicated main effects of group in the start, median 
194 and stop times, all Fs > 5.61, and a group x drug interaction in the start and median times, Fs > 3.41. 
195 These results suggest the larger effect of fluoxetine was in the FEAR rats. Also, similarly to what was 
196 found in the curve fitting analyses, the range of the individual trial analyses was not significantly 
197 different in either Pl or Pl+N trials, supporting the suggestion that the resoo ndi ng curve was simply 
198 delayed. 
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199 Connections between timing delay by fear expression. Individual animal data was plotted on a 
200 regression lir1e for the mean timing delay and fear expression values. The slope of the regression line 
201 was compared to null slope, indicating that there was no relationship . T-tests analyses indicated reliable 
202 differences from a null slope for the FEAR group under the vehicle condition, t{l,12) = 2.53, but were 
203 not significant under the FLX 6ug condit ion, t{l,12) = 1.62. Additionally , the NUETRAL group showed a 
204 statistically significant effect under the FLX 6ug condition, t(l,13) = 2.51, p < 0.05, but were not 
205 significant under the vehicle condition, t(l,13) = 0.77. These results supported a paradoxical relationship 
206 between the drug conditions and the linear regression slopes. 
207 === Figure 5 about here === 
208 Discussion 
209 Our results rievealed a dissociation of the effects of fluoxetine infusion in prelimbic cortex on timing and 
210 working memory for time (resource allocation), and between neutral and anxiety -inducing distraction. 
211 Fluoxetine was effective in preventing memory disruption by negative emotional distracters, but in fact 
212 increased distractibility by neutral distracters. These results are not due to possible changes of the 
213 timing mechanisms, as fluoxetine had no effect on timing in the absence of distracters, and had no 
214 effect on the precision of timing or on the response rate. These results were confirmed by curve fitting 
215 analyses and by analyses of responses in individual-trials. 
216 Similar to what was found in Heilbronner and Meck {2013), the effect of fluoxetine had no impact on 
217 non-interrupted (Pl) probe trials. Serotonin is thought to have a modulatory effect on interval timing, 
218 working memory and action selection (Ho et al, 2002; Rogers, 2011). In the past dopamine has been 
219 found to be pr imarily responsib le for general timing and implicated in distractibility during trials that 
220 have an inte r ruption {Buhusi, 2003; Buhusi and Meck, 2002), as well as an emotional distraction 
221 (Matthews et al, 2012). As such it is important to see that fluoxetine has no impact upon timing without 
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222 distraction. Our results indicated that increased serotonin signaling within the mPFC had no impact on 
223 general timing processes. 
224 Previous studies have also shown a role of SSRI drug dose on anxiolytic effects {Handley and McBlane, 
225 1993; Pinheiro et al, 2007; Salchner and Singewald, 2002; Silva et al, 1999). [AM2JSimilarly, we saw a dose 
226 dependent effect in the FEAR group, where the delay was decreased as the fluoxetine dose increased . 
227 This result was seen in the timing functions as well as the individual-trial ana lyses. However, the 
228 anxiogenic result seen in the timing functions was not able to be teased apart in the individua l-tr ial 
229 ana lyses. This negative result might be due to a lack of power for the analyses . Previous studies have 
230 shown that other analyses have been sensitive enough to find significance in the Pl paradigm, in which 
231 individual-trial analyses found no significance (Buhusi and Matthews, 2013). 
232 Additionally, the regression lines of the FEAR and NEU groups reversed under the effects of fluoxetine, 
233 which supports the paradoxical effect of fluoxetine seen in the timing functions. It is well known that 
234 one possible acute side effect of SSRls is anxiogenesis. There is an existing literature showing paradoxical 
235 effects of SSRls in treatment in both human and animal research {Bagdy et al, 2001; Burghardt et al, 
236 2004). In human studies, antidepressant drugs have to be administered chronically before therapeutic 
237 relief is seen. However, we were able to see an anxiogenic effect by infusing fluoxetine into the mPFC 
238 directly , which suggests that the effect of serotonin might not have a role in timing, but in retaining 
239 attentional processes within the prefrontal cortex. 
240 Previous research has implicated the prefrontal cortex in decision making (Kim et al, 2009), including 
241 distraction from memory tasks (Chao and Knight, 1998 ; Matthews et al, 2012). Indeed the prefrontal 
242 cortex of rats has been shown to be analogous to the frontal cortex of nonhuman primates and humans 
243 (Uylings et al, 2003; Vertes, 2004). The prefrontal cortex has also been implicated in working memory 
244 for time paradigms , such as the interval timing procedure (Buhusi and Meck, 2005; Kim et al, 2009; 
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245 Matthews et al, 2012; Pessoa, 2008). Previous studies have found a high density of serotonin 
246 transporters (SERT) within the cortical areas (Sur et al, 1996). SERT is primarily found on the presynaptic 
247 dendrites and its role is to remove serotonin from the synapse. However with fluo xetine, the SERT is 
248 blocked and serotonin is abnormally available within the synapse . 
249 Animal [AM3J models of PTSD and anxiety disorders have been developed where an animal is given 
250 classical conditioning where a stimulus is followed by an inescapable footshock (Brown et al, 2007; 
251 Matthews et al, 2012). Additionally, the time keeping abilities of animals allow scientists to probe 
252 working memory . Over time, animals develop an accurate representation of a time criterion which can 
253 th en be used as a probe to identify brain components in working memory tasks when anxiety provoking 
254 situations occur . (Buhusi et al, 2005; Matthews et al, 2012). During testing sessions, the stimulus was 
255 presented as a task -irrelevant distracter during the timing task resulting in a delay in responding 
256 suggesting a failure to maintain subjective time in working memory, possibly due to attentional and 
257 working memory resources being diverted away from timing , as proposed by the Relative Time-Sharing 
258 (RTS) model (Buhusi, 2003; Buhusi et al, 2009). 
259 According to the RTS model, both novel and emotional distracters result in attentional processes being 
260 reallocated to the processing of an unexpected stimulus. Previously the attentional processes were 
261 placed onto the primary timing task, however because attentional processes are limited, attention 
262 would be spent on the timing task and upon distracter (Buhusi, 2003; Buhusi et al, 2009) . However in 
263 disorders such as PTSD, greater attentional emphasis is placed onto stressful distracters, taking more of 
264 the attentional resources available. The RTS model allows us to hypothesize that the distracter should 
265 cause the FEAR group to be shifted in a greater magnitude as compared to the NEU group without any 
266 effect of the drug (VEH condition). However, previous studies have shown that the distractibility of a 
267 stressfu l stimulus can be partially eliminated using antidepressants within the mPFC of rats (Matthews 
268 et al, 2012). The RTS model can explain the paradoxical results. While the distracter is not effect ive in 
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269 delaying the timing functions of the NEU group, the NEU group delayed under the effect of FLX, 
270 indicative that increased serotonin redistributed the attentional resources . Conversely, when the 
271 distracter was paired (FEAR) and embedded within the timing task the attentional resources were 
272 redirected upon the noise processing . However, the addition of serotonin might have caused more 
273 resources to be redistributed to processing the timing task. Therefore, we must conclude the serotonin 
274 while having no impact on basal timing, is implicated in the reallocating of attentional processes. 
27S In the United States alone, 11% of people over the age of 12 are taking some form of antidepressant 
276 medication (Pratt et al, 2011), for depression and anxiety disorders. Proper diagnosis of anxiety 
277 disorders are critical to produce optimal patient outcomes and misdiagnosis and treatment can 
278 exacerbate symptoms. For example, fluoxetine reduces anxiety related symptoms in subjects that 
279 demonstrate anxious behavior (Floresca et al, 2011). However, in a population that has no acute 
280 anxiety, fluoxetine treatment has a paradoxical anxiogenic effect (Gorman et al, 1987; Pae et al, 2004). 
281 Similarly, in our experiment, NEUTRAL rats, which received no noise-shock pairings demonstrated 
282 considerable timing delay in Pl+N trials under the high dose of FLX, whereas FEAR rats, which received 
283 noise -shock pairings, were less delayed by the noise. These results suggest that FLX had a differential 
284 effect on the two groups: FLX had an anxiolytic effect when the noise was emotionally charged (FEAR 
28S group), but had an anxiogenic effect when the noise was neutral (NEUTRAL group) . Moreover, this may 
286 also explain the individual differences in the effect of FLX on time delay in our experiment (see Figure S), 
287 as well as individual differences in responsiveness to FLX medication (Oh, 2009) [AM 4](Calil, 2001). 
288 Fluoxetine is indeed used as an anxiogenic inducer in non-anxious rodents (Bagdy et al, 2001), in the 
289 same way that some patients experience an exacerbation of anxiety under FLX treatment. Together with 
290 previous studies, our results support a differential effect of SSRI fluoxetine on working memory for 
291 duration related to the context (neutral/ fear) in which subjects (patients) are given the treatment. 
292 Further studies are required to elucidate the mechanisms of this paradoxical result. 
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457 Figure Legends 
458 Figure 1 Cannulae tip placements. NEUTRAL (n = 14); FEAR (n = 13) . 
459 Figure 2 Response functions during Pl (solid) and noise interrupted Pl+N trials (dashed). Vertical l ines 
460 indicate est im ated peak time in Pl (solid) and Pl+N trials (dashed). Distanc e between vertical lines 
461 represents the delay after noise presentation (black rectangle). Vehicle (VEH, left), fluoxetine 0.6ug (FLX 
462 0.6ug, center), and fluoxetin e (FLX 6ug, right). **p < 0.01. NEUTRAL (n = 14); FEAR (n = 13). 
463 Figure 3 Mean timing delay(± SEM) in Pl+N relat ive to Pl trials . Vehicle {VEH, left) , fluoxetine 0.6ug (FLX 
464 0.6ug, center) , and fluoxe t ine {FLX 6ug, right). Post -hoc compa ri sons * p < 0.05, ** p < 0.01. NEUTRAL (n 
465 = 14); FEAR (n = 13). 
466 Figure 4 Mean(± SEM) st art (left), median (middle), and stop times (right) in Pl+N trials. Post -ho c 
467 comparisons:* p < 0.05, ** p < 0.01. NEUTRAL (n = 14); FEAR (n = 13). 
468 Figure 5 Scatterplots of timing delay by fear expression in NEUTRAL {left, n = 14) and FEAR rats (right, n = 
469 13). Veh icle {VEH, dotted lines) and fluoxetine (FLX 6ug, so lid lines). Fear expression was indexed by the 
470 rate o f decay of freezing behavior after the presentation of the noise in extinction. Less fear expression 
471 (lef t side of the x-axis) was indexed by more negati ve decay rates while more fear expression (right side 
472 of the x-ax is) was index ed by more positive de cay rates . 
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